Claims for Patent: 8,497,071

Summary for Patent: 8,497,071

Title:	Isolation of unknown rearranged T-cell receptors from single cells
Abstract:	Disclosed herein are methods and materials for isolating and identifying T cell receptors from single cells. In some embodiments, genomic DNA from a single T cell is isolated using whole genome amplification (WGA). A series of PCR reactions is carried out to enrich the genomic template for sequences encoding the TCR alpha and beta chains, and then to isolate the sequences encoding the TCR alpha and beta chains.
Inventor(s):	Balazs; Alejandro Benjamin (Berkeley, CA), Tsai; Jonathan Michael (Saratoga, CA), Baltimore; David (Pasadena, CA)
Assignee:	California Institute of Technology (Pasadena, CA)
Application Number:	12/824,744
Patent Claims:	1. A method of isolating DNA encoding the variable regions of a T cell receptor (TCR) alpha or beta chain, said method comprising: (a) isolating genomic DNA from a single T cell; (b) amplifying a gene segment encompassing the TCR alpha or beta chain variable region by an enrichment amplification reaction to produce an enrichment product comprising the V and J regions of the TCR alpha or beta chain from the single cell, the amplification reaction comprising incubating the isolated genomic DNA with a set of outer primers comprising at least one primer complementary to each of the V and J regions of the TCR alpha chain or TCR beta chain. 2. The method of claim 1 wherein the enrichment product is further amplified in an isolation amplification reaction to produce an isolation product, the isolation amplification reaction comprising incubating the enrichment product with a set of inner primers comprising at least one primer complementary to each of the V and J regions of the TCR alpha chain or TCR beta chain. 3. The method of claim 2 wherein the isolation product is further amplified in a cloning amplification reaction to produce a cloning product, the cloning amplification reaction comprising incubating the isolation product with a set of cloning primers comprising at least one primer complementary to each of the V and J regions of the TCR alpha chain or TCR beta chain, and wherein each cloning primer also comprises a vector region that is homologous to a vector. 4. The method of claim 3 wherein the cloning product is further amplified in a homologous amplification reaction to produce a homologous product, the homologous amplification reaction comprising incubating the cloning product with a set of homologous primers that are homologous to the vector region of the cloning primers. 5. The method of claim 1 wherein the amplification reaction comprises a PCR reaction. 6. The method of claim 5, wherein the PCR reaction utilizes a touchdown PCR protocol. 7. The method of claim 1, wherein isolating genomic DNA from a single T cell comprises whole genome amplification. 8. The method of claim 1 additionally comprising screening the isolated genomic DNA obtained in step (a) for the presence of T cell receptor constant regions prior to step (b). 9. The method of claim 1, wherein the outer primers anneal to a sequence about 5 to 40 base pairs upstream of the signal sequence junction of the alpha or beta V region or a sequence about 5 to 50 base pairs downstream of the exon/intron junction of the alpha or beta J region. 10. The method of claim 2, wherein the set of inner primers comprises forward and reverse inner primers, wherein each forward inner primer anneals to a sequence at the start of the first amino acid downstream of the signal sequence of the alpha or beta V region and each reverse inner primer anneals to a sequence at the downstream end of the alpha or beta J region. 11. The method of claim 3, wherein the vector region comprises about 15 bases of homology to the vector. 12. The method of claim 2, additionally comprising sequencing the isolation product. 13. The method of claim 3, additionally comprising inserting the cloning product into the vector. 14. The method of claim 13, wherein the vector is an expression vector. 15. A method of isolating the variable regions of a T-cell receptor (TCR) alpha or beta chain, said method comprising: (a) isolating a single T cell; (b) performing whole genome amplification to amplify the genomic DNA of the T cell; (c) incubating the amplified genomic DNA with a set of outer primers in a genomic TCR alpha enrichment amplification reaction or genomic TCR beta enrichment amplification reaction to produce an enrichment product, wherein the set of primers comprises at least one outer primer substantially complementary to each V and J region of the TCR alpha chain or TCR beta chain; and (d) incubating the enrichment product with a set of inner primers in an TCR alpha isolation amplification reaction or TCR beta isolation amplification reaction to produce an isolation product, wherein the set of inner primers comprises at least one inner primer complementary to each of the V and J regions of the TCR alpha chain or TCR beta chain. 16. The method of claim 15 comprising a step of (e) incubating the isolation product with a set of cloning primers in a cloning amplification reaction to produce a cloning product, wherein the set of cloning primers comprises at least one cloning primer complementary to each of the V and J regions of the TCR alpha chain or TCR beta chain. 17. The method of claim 16 comprising a step of (f) incubating the cloning product with a set of homologous primers in a homologous amplification reaction.

Details for Patent 8,497,071

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2029-06-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2029-06-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2029-06-29